FDA warning letters dive into detail in the January 2018 AHPA Report!

FDA warning letters dive into detail in the January 2018 AHPA Report!

January 2018 AHPA Report

Published: Thursday, January 11, 2018

In this issue of AHPA Report:

Special topic:

FDA warning letters dive into detail by Anthony Young, Esq., Kleinfeld, Kaplan & Becker LLP and AHPA General Counsel

Plus:

  • AHPA submits comments on pre-DSHEA dietary ingredients list

  • AHPA participates in CIR panel discussion on 4 herbal ingredients

  • Industry coalition: Dietary supplements cannot claim to treat opioid addiction

  • AHPA mourns the passing of Jim Duke
    ...and much more!

Print

2018 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.